drugset / Trial / NCT00606034
U-500R Insulin In Type 2 Diabetes With Severe Insulin Resistance Via Omnipod
Non-randomizedSingle-groupOpen-labelTreatment
Summary
Patients with Type 2 diabetes and severe insulin resistance with very large insulin requirements who have failed all previous insulin regimens using non-concentrated forms of insulin (U100 insulin formulations) will receive 5X concentrated insulin (U500 regular insulin)infused via insulin pump.
Timeline
- Start
- 2007-12
- Primary completion
- 2009-07
- Completion
- 2009-07
Publications
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | U-500 Insulin | Unknown | — | Subcutaneous |